# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2081-2090 of 2224 results.
A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma
Status: Terminated
Last Changed: Aug 20, 2020
First Received: Nov 30, 2016
Disease(s): Multiple Myeloma, NonHodgkin Lymphoma
Intervention(s): TAS4464
Locations: Center for Cancer and Blood Disorders, Bethesda, Maryland, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, New Jersey, United States
... and 3 other locations.
Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
Status: Recruiting
Last Changed: Jul 01, 2020
First Received: Jan 21, 2020
Disease(s): Mantle Cell Lymphoma Recurrent
Intervention(s): ibrutinib and Tisagenlecleucel
Locations: Peter Mac Callum Cancer Centre, Melbourne, Victoria, Australia
Allo-hNHL (FluBuCy)
Status: Completed
Last Changed: Jan 13, 2020
First Received: Nov 05, 2008
Disease(s): Non-Hodgkin's Lymphoma
Intervention(s): standard GVHD prophylaxis, rituximab
Locations: Universitätsklinikum Heidelberg, Heidelberg, Baden-Würtenberg, Germany
Universitätsklinikum Marburg, Marburg, Hessen, Germany
Universitätsklinikum und Poliklinik, Homburg, Saarland, Germany
University Hospital Goettingen, Göttingen, Germany
Asklepios Klinik St. Georg, Hamburg, Germany
... and 2 other locations.
Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma
Status: Completed
Last Changed: Mar 26, 2015
First Received: Oct 27, 2005
Disease(s): Lymphoma
Intervention(s): therapeutic autologous lymphocytes, carmustine, cytarabine, etoposide, melphalan, peripheral blood stem cell transplantation (PBSCT)
Locations: Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality
Status: Not yet recruiting
Last Changed: Aug 03, 2020
First Received: Jul 30, 2020
Disease(s): Hypogonadism
Intervention(s): AndroGel
Locations: Copenhagen University Hospital, Copenhagen, Denmark
Herlev University Hospital, Herlev, Denmark
Zealand University Hospital, Roskilde, Denmark
A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE)
Status: Completed
Last Changed: May 15, 2017
First Received: Jul 21, 2008
Disease(s): Non-Hodgkin's Lymphoma
Intervention(s): Rituximab, CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone), CVP (cyclophosphamide, vincristine, prednisone), Analgesic/antipyretic and antihistamine drugs
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
Status: Recruiting
Last Changed: Feb 07, 2020
First Received: Sep 20, 2013
Disease(s): Lymphoid Malignancies, Multiple Myeloma, Lymphoma, Hodgkin Lymphoma, Non-hodgkin Lymphoma
Intervention(s): Pralatrexate, Romidepsin
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Columbia University Irving Medical Center, New York, New York, United States
B-Cell Hematologic Malignancy Vaccination Registry
Status: Enrolling by invitation
Last Changed: Feb 19, 2020
First Received: Nov 24, 2014
Disease(s): Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia, Lymphocytosis, Lymphoma, Non-Hodgkin, B-Cell Chronic Lymphocytic Leukemia, Hematological Malignancies
Locations: Aurora Health Care, Milwaukee, Wisconsin, United States
CD19-redirected Autologous Cells (CAR-CD19 T Cells)
Status: Unknown status
Last Changed: Oct 14, 2016
First Received: Oct 14, 2016
Disease(s): CD19 Positive Malignant B-cell Leukemia and Lymphoma
Intervention(s): CAR-CD19 T cells, Fludarabine, Cyclophosphamide
Locations: Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Infusion of Allogeneic, 3rd Party CD19-specific T Cells
Status: Withdrawn
Last Changed: Jan 22, 2020
First Received: Oct 24, 2014
Disease(s): Blood And Marrow Transplantation, Leukemia, Lymphoma
Intervention(s): Cyclophosphamide, Fludarabine, T-Cell Infusion